Destiny Pharma Plc

Destiny Pharma (DEST)

Company name:Destiny Pharma Plc
EPIC:DESTTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BDHSP575
Market Segment:ASQ1Share Type:DE
WWW Address: GBP0.01
 Price Price Change [%] Bid Offer Open High Low Volume
 101.50 12.5 [14.04] 98.00 105.00 89.00 101.50 89.00 76,453
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 44.47 43.82 0.06 -10.70 - - - 112.00 - 30.00

Destiny Pharma Key Figures

(at previous day's close)
Market Cap.44.47m
Shares In Issue43.82m
Prev. Close89.00
PE Ratio- 
Dividend Yield-%
EPS - basic-10.70p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-10.57p
Return On Equity (ROE)-60.68%
Operating Margin-%
PEG Factor- 
EPS Growth Rate10.08%
Dividends PS Growth Rate-%
Net Debt-6.68m
Gross Gearing9.33%
Quick Assets8.52m
Net Working Capital7.73m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-12.60p
Retained Profit PS-10.75p
Cash PS17.07p
Net Cash PS15.25p
Net Tangible Asset Value PS *17.71p
Net Asset Value PS17.71p
Spread7.00 (6.67%) 

Destiny Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week112.0083.50
4 weeks112.0055.00
12 weeks112.0044.00
1 year112.0030.00

Share Price Chart (5 years)

Destiny Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week83.5018.0021.5683.500.0998.16
4 weeks55.0046.5084.5555.000.0982.82
12 weeks45.0056.50125.5644.000.0864.58
26 weeks45.0056.50125.5630.000.0752.02
1 year41.0060.50147.5630.000.0549.13
3 years133.00-31.50-23.6830.000.0363.51
5 years158.50-57.00-35.9630.000.0373.02

Destiny Pharma Key Management Ratios

Destiny Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 4.11 
Tobin's Q Ratio (excl. intangibles)4.11 
Dividend Yield-%
Market-to-Book Ratio5.73 
Price-to-Pre-Tax Profit PS-8.05 
Price-to-Retained Profit PS-9.45 
Price-to-Cash Flow PS-9.60 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS5.73 
Price-to-Cash PS5.95 
Net Working Capital PS17.63 
Price Pct to Working Capital PS5.76%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Destiny Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-78.08%
Net Gearing (excl. Intangibles)-78.08%
Gross Gearing9.33%
Gross Gearing (excl. Intangibles)9.33%
Gearing Under 1 Year9.33%
Gearing Under 1 Year (excl. Intgbl)9.33%
(Liquidity Ratios)
Net Working Capital to Total Assets90.29%
Current Ratio10.68 
Quick Ratio (Acid Test)10.68 
Liquidity Ratio9.37 
Cash & Equiv/Current Assets87.74%
(Solvency Ratios)
Enterprise Value36.99m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.02 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.14 
Total Debt0.80m
Total Debt/Net Current Assets0.10%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)

Destiny Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-71.16%
Return On Assets (ROA)-43.56%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-60.68%
Return On Investment (ROI)-47.04%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Destiny Pharma Dividends

Sorry No Data Available

Destiny Pharma Fundamentals

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit-3.21--6.01--5.52-m
attributable profit-2.98--5.17--4.71-m
retained profit-2.98--5.17--4.71-m
eps - basic (p)-8.40 -11.90 -10.70 
eps - diluted (p)-8.40 -11.90 -10.70 
dividends per share- - - 

Destiny Pharma Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets0.020.13%0.030.23%0.030.38%m
intangibles intangibles--%--%--%m
fixed investments fixed investments--%--%--%m
current assets - other current assets - other5.0029.27%5.0038.29%--%m
stocks stocks--%--%--%m
debtors debtors0.341.97%0.977.41%1.0412.21%m
cash & securities cash & securities11.7268.63%7.0654.07%7.4887.40%m
creditors - short creditors - short0.402.33%0.806.14%0.809.33%m
creditors - long creditors - long--%--%--%m
creditors - other creditors - other--%--%--%m
subordinated loans subordinated loans--%--%--%m
insurance funds insurance funds--%--%--%m
ord cap, reserves ord cap, reserves16.6997.67%12.2693.86%7.7690.67%m
prefs, minorities prefs, minorities--%--%--%m
NAV Basic- - - 
NAV Diluted- - - 

Destiny Pharma Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-2.15-4.72-4.63m
Pre-Financing CF-7.17-4.660.41m
Retained CF10.24-4.660.42m

Destiny Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Destiny Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201031 10:58:31